Baroness Northover (LD)

My Lords, Amendment 10, in my name and that of my noble friend Lady Walmsley, would require the Secretary of State to make regulations requiring tobacco manufacturers and importers to provide quarterly sales data to assist public health activities. These regulations may include information about, for example, volume of sales, geographical area and product type. Tobacco is not like any other industry, as we have been discussing. The products sold by the industry kill around two-thirds of long-term users and the harms are widespread and well-documented. Yet the industry treats its data as a commercial secret, leaving public health authorities in the dark. The information already exists. The tobacco industry holds it. This amendment would ensure that the data are harnessed for the public good. I note that, although Amendment 10 outlines areas where regulations could be brought, it does say “may”—there is flexibility there for the Government. All that is required is that they make progress in this area. The noble Earl, Lord Howe, noted in Committee that HMRC and the Department of Health currently have access to some data. However, we do not feel that that is sufficient. We have heard from those working in public health that there are gaps which, if filled, would benefit activities on the ground. Smoking is responsible for deep health inequalities, with modelling from Cancer Research UK, for example, showing a 25-year gap between the most and least affluent communities in this country in achieving smoke-free status. That is a shocking illustration of health inequality, reflected in nearly twice as many smoking-related cancers in the poorest areas compared with the wealthiest. Access to sales data would help local authorities, trading standards and public health agencies target resources effectively, monitor patterns of use and respond quickly to emerging threats. Other countries do this. Canada’s Tobacco Reporting Regulations require manufacturers to report on over 20 ingredients and 40 emissions, along with sales and promotion data, to assist Health Canada in policy decisions. Australia requires companies to report on sales volumes, product pricing, advertising, promotion, and sponsorship activities and expenditure, alongside information regarding ingredients. Mandating transparency—we were discussing transparency earlier—is the right step. It holds the tobacco industry more accountable and ensures that public health can act on the evidence, rather than wait for other data sources. For these reasons, I urge the Government to support this amendment and commit to improve transparency for an industry that has avoided accountability for decades. I beg to move.